CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −320,000 | 0 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +320,000 | 320,000 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −106,667 | 0 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +106,667 | 106,667 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −213,333 | 0 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +213,333 | 213,333 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −40,000 | 0 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +40,000 | 40,000 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −200,000 | 0 | ||
| 2019-09-20 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +200,000 | 200,000 | ||
| 2019-09-20 | Catelani Michael COO & CFO | Returned to the company · Employee Stock Option | −50,000 | 0 | ||
| 2019-09-20 | Catelani Michael COO & CFO | Grant or award · Employee Stock Option | +50,000 | 50,000 | ||
| 2019-09-20 | Catelani Michael COO & CFO | Returned to the company · Employee Stock Option | −200,000 | 0 | ||
| 2019-09-20 | Catelani Michael COO & CFO | Grant or award · Employee Stock Option | +200,000 | 200,000 | ||
| 2019-09-20 | Baskies Arnold M Director | Returned to the company · Employee Stock Option | −6,000 | 0 | ||
| 2019-09-20 | Baskies Arnold M Director | Grant or award · Employee Stock Option | +6,000 | 6,000 | ||
| 2019-09-20 | Baskies Arnold M Director | Returned to the company · Employee Stock Option | −12,000 | 0 | ||
| 2019-09-20 | Baskies Arnold M Director | Grant or award · Employee Stock Option | +12,000 | 12,000 | ||
| 2019-09-13 | Titterton Lewis H jr Director | Purchase | +15,000 | $4.10 | $62K | 906,544 |
| 2019-09-13 | KUMAR AMIT Chief Executive Officer | Purchase | +10,000 | $4.12 | $41K | 174,000 |
Page 11 of 21 · 404 trades